Karen Dybkær

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

Zijun Y. Xu‐Monette, Lin Wu, Carlo Visco et al. · Blood · 2012 · 383 citations · Full text

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Carlo Visco, Y Li, Zijun Y. Xu‐Monette et al. · Leukemia · 2012 · 354 citations

Hematological Malignancy, Lymphoid Neoplasia, Engineering +14

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Shimin Hu, Zijun Y. Xu‐Monette, Aarthi Balasubramanyam et al. · Blood · 2013 · 243 citations · Full text

Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL

Ziju Y. Xu-Monette, Min Xiao, Qingyan Au et al. · Cancer Immunology Research · 2019 · 175 citations

Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes With Prognosis

Karen Dybkær, Martin Bøgsted, Steffen Falgreen et al. · Journal of Clinical Oncology · 2015 · 115 citations · Full text